Ketamine Plus Lithium in Treatment-Resistant Depression

NCT01880593 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Depression

Interventions

DRUG: Lithium
DRUG: Ketamine
DRUG: Placebo

Sponsor

Icahn School of Medicine at Mount Sinai